Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
Search
Close this search box.
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
Menu
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Targeting Critical Regulators of Cancer Stem Cells

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective We will develop a small molecule inhibitor that blocks the growth of human pancreatic cancer and AML cancer stem cells in vitro and in vivo. Impact This work…

Continue ReadingTargeting Critical Regulators of Cancer Stem Cells

Development of COVID-19 Antiviral Therapy Using Human iPSC-Derived Lung Organoids

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective To develop a new therapy for COVID-19 using human iPSC-derived lung organoids that targets SARS-CoV-2 protease known as the virus’ “Achilles Heel” Impact Our work, if successful, will…

Continue ReadingDevelopment of COVID-19 Antiviral Therapy Using Human iPSC-Derived Lung Organoids

Drug Development for Autism Spectrum Disorder Using Human Patient iPSCs

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective We will use human patient induced pluripotent stem cell (hiPSC)-based models to screen for a drug that activates a transcription factor critical to the treatment of Autism Spectrum…

Continue ReadingDrug Development for Autism Spectrum Disorder Using Human Patient iPSCs

Small Molecule Proteostasis Regulators to Treat Photoreceptor Diseases

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective We will discover small molecule compounds that correct disease in eyecups (retinal organoids) differentiated from patient iPSCs with photoreceptor diseases. Impact Our small molecule agents will provide new…

Continue ReadingSmall Molecule Proteostasis Regulators to Treat Photoreceptor Diseases

Stimulating endogenous muscle stem cells to counter muscle atrophy

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective Intramuscular delivery of two repurposed FDA approved drugs will activate resident muscle stem cells. This therapeutic strategy will augment regeneration and restore strength to atrophied muscles. Impact Currently…

Continue ReadingStimulating endogenous muscle stem cells to counter muscle atrophy

Discovery of therapeutics for Huntington’s Disease

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective The objective of the proposed research is to perform 3 independent hESC-based screens to identify drug candidates for Huntington’s Disease. Impact There are currently no effective treatments for…

Continue ReadingDiscovery of therapeutics for Huntington’s Disease

A Novel Approach to Eradicate Cancer Stem Cells

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective The outcome is a therapeutic candidate ready for Investigational New Drug (IND)-enabling studies to target a central hub of stemness pathways of cancer stem cells (CSC) maintenance and…

Continue ReadingA Novel Approach to Eradicate Cancer Stem Cells

A Novel Approach to Eradicate Cancer Stem Cells

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective The outcome is a therapeutic candidate ready for Investigational New Drug (IND)-enabling studies to target a central hub of stemness pathways of cancer stem cells (CSC) maintenance and…

Continue ReadingA Novel Approach to Eradicate Cancer Stem Cells

A treatment for Zika virus infection and neuroprotection efficacy

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective We propose to determine the impact of the Zika virus during human neurodevelopment and to test a FDA-approved therapeutic candidate to treat Zika infection. Impact A drug to…

Continue ReadingA treatment for Zika virus infection and neuroprotection efficacy

Protein tyrosine phosphatase – sigma inhibitors for hematopoietic regeneration

  • Post author:
  • Post published:May 20, 2025
  • Post category:

Research Objective We propose to develop a lead small molecule inhibitor of PTPσ, a receptor expressed by human blood stem cells, for the purpose of promoting human hematopoietic regeneration. Impact…

Continue ReadingProtein tyrosine phosphatase – sigma inhibitors for hematopoietic regeneration
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us